#Netherlands #Contact Lenses #Veldhoven #CooperVision #NCC 2026

CooperVision’s Commitment to Improving Contact Lens Wear

CooperVision, a prominent contact lens manufacturer, will showcase its research at the Netherlands Contact Lens Congress (NCC) 2026, held on March 8 and 9 in Veldhoven, Netherlands. This congress, organized under the auspices of the British Contact Lens Association (BCLA), will feature scientific papers and posters that highlight how evidence-based practices alongside continuous innovation enhance clear and comfortable contact lens wear across all life stages.

Marcella McParland, Senior Director of Professional Affairs at CooperVision, emphasized their mission to enhance daily visual experiences. She stated, “Our commitment to improving people’s daily vision means developing advanced contact lens designs and modalities that evolve with their vision needs.” McParland also acknowledged that the research presented aims to foster a better understanding of wearer satisfaction, adjusting to new fitting styles, and prescribing patterns to assist eye care professionals in guiding their patients from their first contact lens experience through presbyopia.

Key Research Findings

Study on Myopia Control

One of the highlighted studies initiated by researchers investigates the shift from single-vision contact lenses to the MiSight® 1 day dual-focus design for myopia control. The study found that young adults reported comparable vision quality and comfort within six months of transition. This underscores the importance of eye care practitioners managing patient expectations regarding comfort and visual quality during the fitting process.

Evaluation of Modern Contact Lens Designs

In another significant study, modern spherical contact lens designs, namely MyDay®, Biofinity®, and Biofinity Energys®, were examined. This research confirmed that these contemporary lenses continue to meet the everyday needs of both new and experienced wearers regarding comfort, vision clarity, and overall performance. Additionally, the posters presented by CooperVision will compare the perspectives of eye care professionals with those of consumers regarding remote eye care, shedding light on the motivations and decision-making processes of new and former contact lens wearers, thus revealing actionable insights for testing offers and adoption.

Multifocal Contact Lenses and Presbyopia

Another aspect of CooperVision's research focuses on multifocal contact lenses concerning presbyopia. Several studies propose a more proactive adjustment opportunity for early presbyopic patients that aligns closely with fitting guidelines' recommendations. Others report encouraging satisfaction rates among hydrogel multifocal wearers transitioning to silicone hydrogel materials and among both new and habitual contact lens wearers who were first equipped with multifocal lenses.

For more detailed insights from these studies, attendees can refer to the 2026 Abstracts section on the Nederlands Contactlens Congres website. This biennial congress is expected to attract thousands of eye care specialists, educators, researchers, and manufacturers from the Netherlands, Europe, and around the globe.

About CooperVision

CooperVision, a division of CooperCompanies (Nasdaq: COO), is one of the world's leading contact lens manufacturers. The company offers a comprehensive range of soft daily disposable lenses and two-week as well as monthly lenses crafted from advanced materials and optical designs, complemented by high-quality gas-permeable and scleral lenses used in orthokeratology. With a rich history of addressing the most challenging vision issues—including astigmatism, presbyopia, childhood myopia, and highly irregular corneas—CooperVision provides the most extensive portfolio of spherical, toric, and multifocal products available.

Their commitment to innovation and tailored professional support brings a refreshing perspective to the market, delivering genuine benefits to customers and wearers. For further information, please visit www.coopervision.com.

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a global leader in medical technology, leveraging its two divisions, CooperVision and CooperSurgical, to assist individuals in experiencing life’s beautiful moments. While CooperVision is a trusted market leader in the contact lens sector improving vision every day, CooperSurgical excels in fertility and women’s health, enabling women, babies, and families to spend more time on the essential aspects of healthcare. With its headquarters in San Ramon, California, CooperCompanies employs over 15,000 individuals and markets products in over 130 countries, positively impacting the lives of more than 50 million each year. Further details can be found at www.coopercos.com.

For media inquiries, please contact:
Mike McDougall, FAAO, APR, Fellow PRSA
McDougall Communications for CooperVision
Email: [email protected]
Phone: +1.585.434.2150